Lava Medtech Acquisition Stock Earnings Per Share
Lava Medtech Acquisition fundamentals help investors to digest information that contributes to Lava Medtech's financial success or failures. It also enables traders to predict the movement of Lava Stock. The fundamental analysis module provides a way to measure Lava Medtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Lava Medtech stock.
Lava |
Lava Medtech Acquisition Company Earnings Per Share Analysis
Lava Medtech's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Lava Medtech Acquisition has an Earnings Per Share of 0.0 times. This is 100.0% lower than that of the Financial Services sector and about the same as Shell Companies (which currently averages 0.0) industry. The earnings per share for all United States stocks is 100.0% higher than that of the company.
Lava Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Lava Medtech's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Lava Medtech could also be used in its relative valuation, which is a method of valuing Lava Medtech by comparing valuation metrics of similar companies.Lava Medtech is currently under evaluation in earnings per share category among its peers.
Lava Fundamentals
Return On Asset | -0.0081 | |||
Shares Owned By Institutions | 10.18 % | |||
Number Of Shares Shorted | 105 | |||
EBITDA | (6.22 M) | |||
Net Income | 4.5 M | |||
Cash And Equivalents | 1.15 M | |||
Cash Per Share | 0.08 X | |||
Total Debt | 92.81 K | |||
Debt To Equity | 4.92 % | |||
Current Ratio | 18.29 X | |||
Book Value Per Share | (0.21) X | |||
Cash Flow From Operations | (658.82 K) | |||
Short Ratio | 1.88 X | |||
Total Asset | 120.67 M | |||
Retained Earnings | (3.01 M) | |||
Working Capital | (3.39 M) | |||
Z Score | -0.24 | |||
Net Asset | 120.67 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Lava Stock
If you are still planning to invest in Lava Medtech Acquisition check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Lava Medtech's history and understand the potential risks before investing.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
CEOs Directory Screen CEOs from public companies around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |